Panion & Bf Biotech Inc. (TPE:1760)
Taiwan · Delayed Price · Currency is TWD 64.40
-1.50 (-2.28%)
May 8, 2026, 1:30 PM CST
Panion & Bf Biotech Market Cap
Panion & Bf Biotech has a market cap or net worth of 5.52 billion as of May 8, 2026. Its market cap has decreased by -0.92% in one year.
Market Cap
5.52B
Enterprise Value
5.73B
Revenue
2.06B
Ranking
n/a
PE Ratio
29.14
Stock Price
64.40
Market Cap Chart
Since September 30, 2004, Panion & Bf Biotech's market cap has increased from 534.45M to 5.52B, an increase of 933.13%. That is a compound annual growth rate of 11.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 5.52B | 2.22% |
| Dec 31, 2025 | 5.40B | -23.26% |
| Dec 31, 2024 | 7.04B | -26.70% |
| Dec 29, 2023 | 9.60B | -37.43% |
| Dec 30, 2022 | 15.35B | 138.03% |
| Dec 30, 2021 | 6.45B | -1.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 6.73B |
| Mycenax Biotech | 5.92B |
| Sinphar Pharmaceutical | 5.83B |
| Savior Lifetec | 5.82B |
| AnnJi Pharmaceutical | 5.70B |
| UnicoCell Biomed | 5.30B |
| Steminent Biotherapeutics | 5.00B |
| Medigen Biotechnology | 4.60B |